Koji Ishida
Director/Board Member at Sumitomo Pharma America, Inc.
Koji Ishida active positions
| Companies | Position | Start | End |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Director/Board Member | - | - |
Career history of Koji Ishida
Former positions of Koji Ishida
| Companies | Position | Start | End |
|---|---|---|---|
| BANK OF JAPAN | Director/Board Member | 2011-06-29 | 2016-06-28 |
| SUMITOMO CORPORATION | Director/Board Member | 2017-05-31 | - |
| Independent Dir/Board Member | 2017-05-31 | - |
Training of Koji Ishida
| Graduate School of Economics University of Tokyo | Undergraduate Degree |
Statistics
International
| Japan | 4 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Government | 2 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BANK OF JAPAN | Government |
| SUMITOMO CORPORATION | Distribution Services |
| Private companies | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Stock Market
- Insiders
- Koji Ishida
- Experience
